Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CONMED Corp lowers FY 2014 outlook


Wednesday, 23 Jul 2014 07:02am EDT 

CONMED Corp:Expects FY 2014 sales to be in the range of $735 - $745 mln, compared to prior guidance of $770-780 mln.Expects FY 2014 earnings per share to be in the range $1.85 - $1.95 compared to prior guidance of $1.90 - $2.00.FY 2014 revenue of $766 mln, EPS of $1.94 - Thomson Reuters I/B/E/S. 

Company Quote

47.64
0.03 +0.06%
30 Jan 2015